Antibodies that inhibit malaria merozoite surface protein-1 processing and erythrocyte invasion are blocked by naturally acquired human antibodies

Journal of Experimental Medicine

Volumn 186, Issue 10, 1997, Pages 1689-1699

  Guevara Patiño, José A ^a   Holder, Anthony A ^a   McBride, Jana S ^b   Blackman, Michael J ^a  

^a NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN; MONOCLONAL ANTIBODY; PARASITE ANTIGEN; POLYCLONAL ANTIBODY;

ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; MALARIA; MEROZOITE; NONHUMAN; PARASITISM; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTEIN PROCESSING;

ANIMALS; ANTIBODIES, BLOCKING; ANTIBODIES, PROTOZOAN; ANTIBODY SPECIFICITY; ANTIGEN PRESENTATION; ANTIGENS, PROTOZOAN; BINDING SITES, ANTIBODY; BINDING, COMPETITIVE; ERYTHROCYTES; HUMANS; IMMUNITY, NATURAL; IMMUNODOMINANT EPITOPES; MALARIA, FALCIPARUM; MEROZOITE SURFACE PROTEIN 1; MICE; PLASMODIUM FALCIPARUM; PROTEIN PRECURSORS; PROTOZOAN PROTEINS; RABBITS;

EID: 0344717267     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.186.10.1689     Document Type: Article

References (48)

1. Cohen, S., I.A. McGregor, and S.C. Carrington. 1961. Gamma globulin and acquired immunity to human malaria. Nature (Lond.). 192:733-737.
2. Edozien, J.C., H.M. Gilles, and I.O.K. Udeozo. 1962. Adult and cord-blood gamma-globulin and immunity to malaria in Nigerians. Lancet. 2:951-955.
3. McGregor, I.A., S.P. Carrington, and S. Cohen. 1963. Treatment of East African Plasmodium falciparum malaria with West African human gamma globulin. Trans. R. Soc. Trop. Med. Hyg. 57:170-175.
4. Bouharoun-Tayoun, H., P. Attanath, A. Sabchareon, T. Chongsuphajaisiddhi, and P. Druilhe. 1990. Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes. J. Exp. Med. 172:1633-1641.
5. Holder, A.A. 1994. Proteins on the surface of the malaria parasite and cell invasion. Parasitology. 108:S5-S18.
6. Barnwell, J.W., and M.R. Galinski. 1991. The adhesion of malaria merozoite proteins to erythrocytes: a reflection of function? Res. Immunol. 142:666-672.
7. r 185,000 glycoprotein from the surface of isolated Plasmodium falciparum merozoites form an antigenic complex. Mol. Biochem. Parasitol. 23:71-84.
8. Holder, A.A., J.S. Sandhu, Y. Hillman, L.S. Davey, S.C. Nicholls, H. Cooper, and M.J. Lockyer. 1987. Processing of the precursor to the major merozoite antigens of Plasmodium falciparum. Parasitology. 94:199-208.
9. Blackman, M.J., H.-G. Heidrich, S. Donachie, J.S. McBride, and A.A. Holder. 1990. A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies. J. Exp. Med. 172:379-382.
10. Blackman, M.J., H. Whittle, and A.A. Holder. 1991. Processing of the Plasmodium falciparum major merozoite surface protein-1: identification of a 33-kilodalton secondary processing product which is shed prior to erythrocyte invasion. Mol. Biochem. Parasitol. 49:35-44.
11. 33 as a noncovalently associated complex with other fragments of the MSP1. Mol. Biochem. Parasitol. 50:307-316.
12. Stafford, W.H.L., M.J. Blackman, A. Harris, S. Shai, M. Grainger, and A.A. Holder. 1994. N-terminal amino acid sequence of the Plasmodium falciparum merozoite surface protein-1 (MSP-1) polypeptides. Mol. Biochem. Parasitol. 66: 157-160.
13. Blackman, M.J., J.A. Chappel, S. Shai, and A.A. Holder. 1993. A conserved parasite serine protease processes the Plasmodium falciparum merozoite surface protein-1 (MSP1). Mol. Biochem. Parasitol. 62:103-114.
14. O'Dea, K.P., P.G. McKean, A. Harris, and K.N. Brown. 1995. Processing of the Plasmodium chabaudi chabaudi AS merozoite surface protein 1 in vivo and in vitro. Mol. Biochem. Parasitol. 72:111-119.
15. Blackman, M.J., E.D. Dennis, E.M.A. Hirst, C.H. Kocken, T.J. Scott-Finnigan, and A.W. Thomas. 1996. Plasmodium knowlesi: secondary processing of the malaria merozoite surface protein-1. Exp. Parasitol. 83:229-239.
16. McKean, P.G., K. O'Dea, and K.N. Brown. 1993. A single amino acid determines the specificity of a monoclonal antibody which inhibits Plasmodium chabaudi AS in vivo. Mol. Biochem. Parasitol. 62:211-222.
17. Majarian, W.R., T.M. Daly, W.P. Weidanz, and C.A. Long. 1984. Passive immunization against murine malaria with an IgG3 monoclonal antibody. J. Immunol. 132:3131-3137.
18. Ling, I.T., S. Ogun, and A.A. Holder. 1993. Immunization against malaria with a recombinant protein. Parasite Immunol. (Oxf.). 16:63-67.
19. Daly, T.M., and C.A. Long. 1993. A recombinant 15-kilodalton carboxyl-terminal fragment of Plasmodium yoelii yoelii 17XL merozoite surface protein 1 induces a protective immune response in mice. Infect. Immun. 61:2462-2467.
20. Tian, J.-H., L.H. Miller, D.C. Kaslow, J. Ahlers, M.F. Good, D.W. Alling, J.A. Berzofsky, and S. Kumar. 1996. Genetic regulation of protective immune response in congenic strains of mice vaccinated with a subunit malaria vaccine. J. Immunol. 125:1176-1183.
21. Hui, G.S.N., and W.A. Siddiqui. 1987. Serum from Pf195 protected Aotus monkeys inhibit Plasmodium falciparum growth in vitro. Exp. Parasitol. 64:519-522.
22. Chang, S.P., H.L. Gibson, C.T. Lee-Ng, P.J. Barr, and G.S.N. Hui. 1992. A carboxyl-terminal fragment of Plasmodium falciparum gp195 expressed by a recombinant baculovirus induces antibodies that completely inhibit parasite growth. J. Immunol. 149:548-555.
23. Pirson, P.J., and M.E. Perkins. 1985. Characterization with monoclonal antibodies of a surface antigen of Plasmodium falciparum merozoites. J. Immunol. 134:1946-1951.
24. Cooper, J.A., L.T. Cooper, and A.J. Saul. 1992. Mapping of the region predominantly recognized by antibodies to the Plasmodium falciparum merozoite surface antigen MSA 1. Mol. Biochem. Parasitol. 51:301-312.
25. Blackman, M.J., T.J. Scott-Finnigan, S. Shai, and A.A. Holder. 1994. Antibodies inhibit the protease-mediated processing of a malaria merozoite surface protein. J. Exp. Med. 180:389-393.
26. Burghaus, P., and A.A. Holder. 1994. Expression of the 19-kilodalton carboxy-terminal fragment of the Plasmodium falciparum merozoite surface protein-1 in Escherichia coli produces a correctly folded protein that is recognized by protective monoclonal antibodies. Mol. Biochem. Parasitol. 64:165-169.
27. Holder, A.A., and R.R. Freeman. 1981. Immunization against blood-stage rodent malaria using purified parasite antigens. Nature (Lond.). 294:361-366.
28. Antibodies. A Laboratory Manual. 1988. E. Harlow and D. Lane, editors. Cold Spring Harbor Laboratory, New York.
29. Smith, D.B., and K.S. Johnson. 1988. Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene (Amst.). 67:31-40.
30. Abath, F.G.C., and A.J.G. Simpson. 1990. A simple method for the recovery of purified recombinant peptides cleaved from glutathione S-transferase fusion proteins. Peptide Res. 3:167-168.
31. Miller, L.H., T. Roberts, M. Shahabuddin, and T.F. McCutchan. 1993. Analysis of sequence diversity in the Plasmodium falciparum merozoite surface protein-1 (MSP-1). Mol. Biochem. Parasitol. 59:1-14.
32. Steers, E., P. Cuatrecasas, and H.B. Pollard. 1971. The purification of β-galactosidase from E. coli by affinity chromatography. J. Biol. Chem. 246:196-200.
33. Fraker, J.P., and J.C. Speck. 1978. Protein and cell membrane iodination with a sparingly soluble chloramide 1,3,4,6,-tetrachloro-3α,6α-diphenylglycoluril. Biochem. Biophys. Res. Commun. 80:849-857.
34. Blackman, M.J. 1994. Purification of Plasmodium falciparum merozoites for analysis of the processing of merozoite surface protein-1. Methods Cell Biol. 45:213-220.
35. Blackman, M.J., and A.A. Holder. 1993. Use of a recombinant baculovirus product to measure naturally-acquired human antibodies to disulphide-constrained epitopes on the P. falciparum merozoite surface protein-1 (MSP1). FEMS Immunol. Med. Microbiol. 6:307-316.
36. Blackman, M.J., I.T. Ling, S.C. Nicholls, and A.A. Holder. 1991. Proteolytic processing of the Plasmodium falciparum merozoite surface protein-1 produces a membrane-bound fragment containing two epidermal growth factor-like domains. Mol. Biochem. Parasitol. 49:29-34.
37. Chappel, J.A., and A.A. Holder. 1993. Monoclonal antibodies that inhibit Plasmodium falciparum invasion in vitro recognise the first growth factor-like domain of merozoite surface protein-1. Mol. Biochem. Parasitol. 60:303-312.
38. Wilson, C.F., R. Anand, J.T. Clark, and J.S. McBride. 1987. Topography of epitopes on a polymorphic antigen of Plasmodium falciparum determined by the binding of monoclonal antibodies in a two-site radioimmunoassay. Parasite Immunol. (Oxf.). 9:737-746.
39. Dvorak, J.A., L.H. Miller, W.C. Whitehouse, and T. Shiroishi. 1975. Invasion of erythrocytes by malaria merozoites. Science (Wash. DC). 187:748-750.
40. Stafford, W.H., B. Günder, A. Harris, H.-G. Heidrich, A.A. Holder, and M.J. Blackman. 1996. A 22 kDa protein associated with the Plasmodium falciparum merozoite surface protein-1 complex. Mol. Biochem. Parasitol. 80:159-169.
41. Riley, E.M., S.J. Allen, J.G. Wheeler, M.J. Blackman, S. Bennett, B. Takacs, H.-J. Schonfelds, A.A. Holder, and B.M. Greenwood. 1992. Naturally acquired cellular and humoral immune responses to the major merozoite surface antigen of Plasmodium falciparum are associated with reduced malaria morbidity. Parasite Immunol. (Oxf.). 14:321-337.
42. Egan, A.F., J. Morris, G. Barnish, S. Allen, B.M. Greenwood, D.C. Kaslow, A.A. Holder, and E.M. Riley. 1996. Clinical immunity to Plasmodium falciparum malaria is associated with serum antibodies to the 19-kDa C-terminal fragment of the merozoite surface antigen, PfMSP-1. J. Infect. Dis. 173:765-769.
43. Chappel, J.A., A.F. Egan, E.M. Riley, P. Druilhe, and A.A. Holder. 1994. Naturally acquired human antibodies which recognize the first epidermal growth factor-like module in the Plasmodium falciparum merozoite surface protein 1 do not inhibit parasite growth in vitro. Infect. Immun. 62:4488-4494.
44. Holder, A.A., and M.J. Blackman. 1994. What is the function of MSP-1 on the malaria merozoite? Parasitol. Today. 10: 182-184.
45. Miller, L.H., M.F. Good, and D.C. Kaslow. 1997. The need for assays predictive of protection in development of malaria bloodstage vaccines. Parasitol. Today. 13:46-47.
46. Kumar, S., A. Yadava, D.B. Keister, J.H. Tian, M. Ohl, K.A. Perdue-Greenfield, L.H. Miller, and D.C. Kaslow. 1995. Immunogenicity and in vivo efficacy of recombinant Plasmodium falciparum merozoite surface protein-1 in Aotus monkeys. Mol. Med. 1:325-332.
47. Chang, S.P., S.E. Case, W.L. Gosnell, A. Hashimoto, K.J. Kramer, L.Q. Tam, C.Q. Hashiro, C.M. Nikaido, H.L. Gibson, C.T. Lee-Ng et al. 1996. A recombinant baculovirus 42-kilodalton C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 protects Aotus monkeys against malaria. Infect. Immun. 64:253-261.
48. Tanabe, K., M. Mackay, M. Goman, and J.G. Scaife. 1987. Allelic dimorphism in a surface antigen gene of the malaria parasite Plasmodium falciparum. J. Mol. Biol. 195:273-287.